Transcripts for interleukin (IL) 15 were detected in the gastric mucosal samples of 5/5 (100%) patients with no evidence of Helicobacter pylori infection and in 4/14 (28%) H. pylori-infected patients (P 6 0.05). Both IL-15 mRNA and IL-15 protein were detected in 1/6 (17%) patients who successfully underwent H. pylori eradication therapy, before treatment and in 5/6 (83%) cases after eradication. Even though a parallel significant (P 6 0.03) improvement of gastritis score occurred after eradication, the severity of gastritis did not differ according to the mucosal IL-15 expression among H. pylori-infected patients, irrespective of the CagA serology. This study demonstrates, for the first time, that transcripts for IL-15 are expressed in the human gastric mucosa. Changes occurring during H. pylori colonisation and after eradication raise the hypothesis that H. pylori may downregulate IL-15 expression in the gastric mucosa. ß
Introduction
Interleukin (IL) 15 is a novel 14^15-kDa pleiotropic cytokine expressed in di¡erent cell types, including intestinal epithelial cells and activated monocytes and macrophages. It shares two receptor subunits and a number of functional e¡ects with IL-2 such as leukocyte recruitment and Th1 immune response regulation [1] . These observations are consistent with studies showing that IL-15 stimulates the proliferation of natural killer cells and acts as a costimulator with IL-12 to facilitate the production of interferon-Q by these cells [2] . However, IL-15 also induces IL-5 production from allergen-speci¢c human T-cell clones [3] and supports B-cell proliferation and immunoglobulin synthesis in vitro [4] , implying a positive role in Th2-mediated responses.
Recent experiments show that intestinal epithelial cells both express and respond to IL-15, suggesting that IL-15 may integrate intestinal epithelial cell function with the intestinal immune system [5] .
The host immune and in£ammatory response is emerging as the crucial element in the pathogenesis of Helicobacter pylori-associated gastro-duodenal diseases [6] . Although there is mounting evidence from many laboratories to support the hypothesis that Th2 cells are very important in bacterial clearance, studies indicate that Th1-like immune response along with chronic active leukocyte in¢ltration and a perturbation of cytokine networks are features of H. pylori-associated gastritis [7^9] . In this study we explored whether IL-15 is involved in the mucosal immune response during H. pylori-associated gastritis. Speci¢c aims were: (1) to determine whether IL-15 is expressed in the human gastric mucosa; (2) to investigate whether mucosal IL-15 is dysregulated during active H. pylori gastritis; (3) to examine whether H. pylori eradication in£uences mucosal IL-15 expression.
Materials and methods

Patients and samples
Nineteen patients (12 men, 7 women; age range 18^75 years, median 42) who underwent gastroscopy (Olympus GIF V3) for dyspeptic complaints were studied; 17 had non-ulcer dyspepsia and two had duodenal ulcer. Eight patients with evidence of H. pylori infection were given a 1-week triple therapy consisting of clarithromycin (2U250 mg day 31 ), tinidazole (2U500 mg day 31 ), and lansoprazole (2U30 mg day 31 ) and were re-endoscoped after 6^8 weeks. During endoscopy, eight antral and corpus biopsies were taken from each patient. Two antral and one corpus samples were used for gastric histology and one antral sample for urease quick test (Yamanouchi Pharma, Milan, Italy; 94% sensitivity, 100% speci¢c-ity). The remaining two antral and two corpus samples were utilised for IL-15 analysis. To evaluate whether H. pylori could a¡ect other cytokines produced by intestinal epithelial cells, the expression of IL-7 was further assessed in the antral and corpus mucosal samples of nine patients.
Gastric histology
Sections of biopsy specimens were stained with haematoxylin and eosin to examine gastritis and with Giemsa to detect H. pylori. The degree and activity of gastritis and the density of H. pylori colonisation, atrophy, and intestinal metaplasia were graded according to the Sydney system [10] on a 4-point scale: no (0), mild (1), moderate (2) , and severe (3) changes.
H. pylori status
In order to avoid false-negative and false-positive ¢ndings, untreated and treated patients were classi¢ed as H. pylori-positive or -negative when both the urease quick test and Giemsa-stained sections in either antral and/or corpus gastric samples were concordantly positive or negative. H. pylori eradication was further assessed by means of the urea C13 breath test (Cortex, Italy) as it is especially valuable for following up patients after therapy (98% sensitivity, 95% speci¢city; personal data).
Serologic assays
Serum samples from each patient were tested for IgG antibodies to H. pylori (Helori-IgG, Eurospital, Italy; 94% sensitivity, 84% speci¢city) and to the cytotoxin-associated gene (CagA) (Helori-CTX IgG, Eurospital, Italy; 94.1% sensitivity, 97.9% speci¢city) by enzyme-linked immunosorbent assay (ELISA).
Gastric tissue homogenate preparation for RNA analysis
Gastric biopsy specimens were used for RNA analysis on freshly obtained whole tissue. One biopsy was taken from the antrum and one from the corpus of each patient. Antral and corpus biopsy specimens were separately placed in guanidine thiocyanate buffer on ice, homogenised using a tissue homogeniser (Ystral GmbH, PBI International, Dottingen, Germany) and immediately used for RNA extraction.
RNA and complementary-DNA preparation
Total RNA was extracted from mucosal samples according to Chomczynsky and Sacchi [11] . The sample obtained was quantitated by absorbance at 260 nm. RNA integrity was assessed by electrophoresis on a 1.5% agarose gel. Complementary DNA (cDNA) was synthetised from 0.5 Wg of total RNA using 0.2 U of murine leukaemia virus reverse transcriptase (Promega, Madison, WI, USA), 2.5 WM random hexamers (Boehringer-Mannheim, Mannheim, Germany), 1 mM dNTP (Boehringer-Mannheim), 2 U RNase inhibitor (Promega) in a total volume of 20 Wl. The reaction was performed at 37³C for 60 min.
Reverse-transcription polymerase chain reaction
Prior to examining transcripts for IL-15 (200 bp) and IL-7 (323 bp), sample cDNA content was normalised on L-actin (485 bp) signal. For this purpose, 5 Wl of cDNA was incubated in a reverse-transcription polymerase chain reaction (RT-PCR) for 19, 21, 23, 25 and 35 cycles with speci¢c L-actin primers. IL-15 and IL-7 primers were assayed on all samples by incubating the same amount of cDNA for 35 cycles. PCR reactions were performed in a total volume of 50 Wl in the presence of 1 U of Taq DNA Polymerase (Boehringer-Mannheim), 200 Wmol dNTPs (Boehringer-Mannheim) and 25 pmol l 31 5P and 3P primers. Reactions were incubated in a Robocycler thermal cycler (Stratagene, La Jolla, CA, USA) (denaturation 1 min at 94³C; annealing for 1 min at 57³C for both L-actin and IL-15 and for 1 min at 55³C for IL-7; extension for 1 min at 72³C). PCR primers (Genosys, Cambridge, UK) were as follows: IL-15: 5P-GTATTGTAGGAGGCATCGTG-3P; 3P-GAAGCTGGCATTCATGTCTTC-5P; IL-7: 5P-G-GACTACCACATGAACTCTG-3P; 3P-CATATCT-TGGCCAAGTGTTAC-5P; L-actin: 5P-CGAGGC-CCAGAGCAAGAGA-3P; 3P-CGTGACATTAAG-GAGAAGCT GTG-5P.
In order to exclude the ampli¢cation of genomic DNA contaminating the samples, we used primers derived from separate exons and experiments were also performed using RNA as substrate for PCR assay. 10 Wl PCR product was combined with 1 Wl of loading bu¡er and electrophoresed on a 1.5% agarose gel (in Tris-ethylenediaminetetraacetic acid bu¡er). A 123-bp ladder was used to assess sample size. The speci¢city of the PCR products for IL-15 was con¢rmed by restriction enzyme analysis. For this purpose the ampli¢ed IL-15 product was digested with RsaI (Boehringer-Mannheim) into two fragments of 116 and 82 bp.
IL-15 enzyme-linked immunosorbent assay
To examine whether IL-15 was produced in the human gastric mucosa, one antral biopsy specimen was taken from the eight patients who underwent H. pylori eradication therapy. Samples were weighed and immediately placed in 1 ml lysis bu¡er containing 10 Wg ml 31 aprotinin (Sigma Chemicals, St. Louis, MO, USA), and homogenised on ice. After running at 3000Ug for 30 min at 4³C, supernatants were collected and stored at 380³C until assay. Samples were normalised for tissue weight before testing IL-15. IL-15 was measured using a sensitive ELISA (Genzyme Corporation, Cambridge, MA, USA). According to the manufacturer's directions the minimum detectable IL-15 concentration was 10 pg ml 31 .
Statistics
Data are presented as mean values with standard deviation (S.D.). Frequencies were compared by means of Fisher's exact test. The Wilcoxon signed rank test was used with paired data, and the Mann-Whitney U-test with unpaired data. A P value of less than 0.05 was considered signi¢cant.
Results
Fourteen out of the 19 (73%) dyspeptic patients had evidence of H. pylori infection. Eight out of these 14 (57%) H. pylori-infected patients tested positive for IgG antibodies to CagA. Five patients had no evidence of H. pylori infection by either biopsybased or serological tests. Transcripts for IL-15 were detected in all patients with no evidence of H. pylori infection (5/5, 100%) and in four out of the 14 (28%) H. pylori-infected patients (P 6 0.05). In each patient, the ¢nding of IL-15 mRNA did not di¡er between antral and corpus biopsy samples. Six patients successfully underwent H. pylori eradication therapy: both IL-15 mRNA and IL-15 protein (35 pg ml 31 ) were detected in only one case before treat-ment and in ¢ve cases (60 þ 33 pg ml 31 ) after eradication. Fig. 1 shows that in four cases IL-15 mRNA was not detected before treatment while it was detectable after eradication of H. pylori, in one case it was detected before treatment and after eradication, and in one case it was detected neither before treatment nor after eradication. A signi¢cant improvement of gastritis score in both the antrum (P 6 0.03) and corpus (P 6 0.03) mucosa occurred after eradication of H. pylori (Table 1) . However, no di¡erences emerged in the gastritis score among patients with evidence of H. pylori infection, according to IL-15 expression, irrespective of the CagA serology (Table 2) . Transcripts for IL-7 were detected in all tested samples (antrum and corpus, n = 18), irrespective of H. pylori and IL-15 status.
Discussion
In recent years, attention in the pathogenesis of infectious diseases has focused on the principal mediators which orchestrate the in£ammatory response, namely cytokines. Furthermore, it has become apparent that bacteria produce many molecules which deeply a¡ect the capacity of leukocytes and tissue cells to produce selected cytokine networks [12] . Infection with H. pylori is associated with an abundant in£ammatory response and epithelial cell injury in human gastric mucosa which may lead to peptic ulcer, gastric lymphoma and carcinoma as opposed to patients with gastritis alone. The host response to natural infection, perhaps triggered by speci¢c strains or regulated by speci¢c host factors, may be inappropriate to clear the organism thus contributing to the spectrum of H. pylori-associated diseases. It has been proposed that an excessive Th1 response driven by H. pylori, through the production of the speci¢c cytokines, increases in£ammation and epithelial damage and may account for the persistence of the infection [6] . In fact, a de¢nite Th2 response which seems to be more important in the generation of mucosal secretory immune responses and protective immunity has not been documented in H. pyloriassociated gastritis [6] . Moreover, protection against extracellular bacteria (i.e. H. pylori) is widely thought to depend mainly on neutrophils and antibodies [13] .
IL-15 is a pleiotropic cytokine which exerts di¡er-ent e¡ects but whether it prejudices Th1 or Th2 differentiation is unclear [14] . This study demonstrated, for the ¢rst time, that transcripts for IL-15 are expressed in the human gastric mucosa and that IL-15 The severity of gastritis was graded according to the Sydney system [10] . Data are given as mean þ S.D. *P v 0.5, compared to data from IL-15-negative patients. a Two (50%) patients tested positive for CagA serology. b Six (60%) patients tested positive for CagA serology. The role of IL-15 in the host defence against bacterial infections is not yet elucidated. It could o¡er a contribution to the early phase of immune responses, providing enhancement of polymorphonuclear and natural killer cell responses, and subsequently Tcell responses, prior to optimal IL-2 production [14] . The main function of activated polymorphonuclear cells is to phagocytose and kill microbial pathogens. Production of IL-15 in the early steps of the in£ammatory response to pathogens might increase the number of polymorphonuclear cells in¢ltrating the tissues.
The ¢ndings of this preliminary study raise the hypothesis that H. pylori may down-regulate IL-15 expression so interfering with the innate immune gastric mucosal response to the bacterium. Further experiments are needed to con¢rm whether IL-15 is involved in the protection against H. pylori and to explore the interrelationship between IL-15 and Th1/ Th2 cytokine networks underlying the host response to H. pylori infection.
